Risk of Stroke or Systemic Embolism in Atrial Fibrillation Patients Treated With Warfarin | Zendy

Ida Ehlers Albertsen | Zendy; Lars Hvilsted Rasmussen | Zendy; Thure Filskov Overvad | Zendy; Tina Graungaard | Zendy; Torben Bjerregaard Larsen | Zendy; Gregory Y.H. Lip | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Risk of Stroke or Systemic Embolism in Atrial Fibrillation Patients Treated With Warfarin

Author(s) -

Ida Ehlers Albertsen,

Lars Hvilsted Rasmussen,

Thure Filskov Overvad,

Tina Graungaard,

Torben Bjerregaard Larsen,

Gregory Y.H. Lip

Publication year - 2013

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.113.000883

Subject(s) - medicine , atrial fibrillation , stroke (engine) , warfarin , aspirin , relative risk , vitamin k antagonist , confidence interval , cardiology , embolism , mechanical engineering , engineering

Although oral anticoagulants (OACs) are highly effective in reducing stroke risk in atrial fibrillation, some patients still sustain stroke despite being on an OAC. Our aim was to identify the risk factors that contribute to stroke risk in atrial fibrillation, although patients were taking OACs in a clinical trial setting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research